American Well Corporation
NYSE:AMWL · New York Stock Exchange
-$0.05 today
Vol 0.04M · Avg 0.08M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+28.85%
Period High
$9.83
Period Low
$3.78
Latest
$8.62
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
ALX Oncology Holdings Inc.
NASDAQ:ALXO
$212.61M
Immunic, Inc.
NASDAQ:IMUX
$136.78M
Repare Therapeutics Inc.
RPTX
$114.24M
Adverum Biotechnologies, Inc.
ADVM
$96.26M
CAMP4 Therapeutics Corporation
NASDAQ:CAMP
$89.00M
Precision BioSciences, Inc.
NASDAQ:DTIL
$78.25M
Biomea Fusion, Inc.
NASDAQ:BMEA
$69.61M
Fractyl Health, Inc. Common Stock
NASDAQ:GUTS
$61.36M
aTyr Pharma, Inc.
ATYR
$43.18M
EUDA Health Holdings Limited
EUDA
$28.39M
What is the latest AMWL filing?
The latest filing shown is DEFA14A dated Jun 9, 2026.
How many recent filings does AMWL have?
Intrinsic Alpha currently shows 20 recent filings for AMWL.
Explore More
Continue the stock analysis
Jump to another research area for this company.